Results
Filtros
Proposal to restrict Cannabis importation (RDC 660) sparks reaction in the market
Proposal in the review of RDC 327/2019 to RDC 660/2022 divides opinions and raises doubts about access and judicialization
How RDC 660 ensures diversified products and support for doctors in different diseases
Paula Scanapieco, a specialist in medical cannabis logistics, speaks on Deusa Cast about the importance of RDC 660, product quality, and the role of companies in providing reliable information to doctors and patients in Brazil
Review of RDC 660 reignites debate on competitiveness and access to imported products
Anvisa proposes exclusive process for the regulation and experts point out impact on the sector
Deusa Cast discusses the update of RDC 660 and access to medicinal cannabis in Brazil
Episode addresses the update of RDC 660, international certification, and challenges to expand access to treatments with different cannabinoids in Brazil.
Anvisa proposes new RDC for medicinal cannabis products and maintains RDC 660 out of the review
Anvisa's proposal establishes a new regulatory framework for industrialized medicinal cannabis products in Brazil
"More than business, it's life," says Paula Scanapieco talking about RDC 660 and international logistics
Paula Scanapieco, commercial manager at Mile Express, explains on Deusa Cast how RDC 660 ensures access for Brazilian patients to cannabis medications through international logistics
"More than business, it's life," says Paula Scanapieco talks about RDC 660 and international logistics
Paula Scanapieco, commercial manager at Mile Express, explains on Deusa Cast how RDC 660 ensures access for Brazilian patients to cannabis medications through international logistics
Anvisa to resume voting on RDC 327 in the first meeting of 2026
Norm review may limit imports via RDC 660 if there is a national equivalent; director Thiago Campos presents dissenting vote
Anvisa suspends review of RDC 327 after director's request for further analysis
Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence
Anvisa suspends review of RDC 327 after director's request for further analysis
Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence
Is the current model of medicinal cannabis importation sustainable for the Brazilian market?
Experts point out regulatory and operational bottlenecks that challenge the consolidation of the national market, even after the advances of RDC 660/2022
Request Authorization to Import Cannabis-Derived Products
01/01/2024Follow the instructions to initiate the import process through RDC 660
ICR launches petition to defend access to imported medicinal cannabis in Brazil
National mobilization seeks to maintain Anvisa's RDC 660/2022 and avoid risks to the continuity of treatments for thousands of patients
Cannabis: RDC 327 Review May Enhance Safety for Dentists in 2026
CFO supports dentists among authorized professionals to prescribe safely and with quality
Anvisa approves new Cannabis regulation and allows compounding pharmacies
Revision of RDC 327 allows the compounding sector to produce derivatives, while individual importation by individuals remains under old rules and will be analyzed separately
Anvisa concludes public consultation on new regulation of Cannabis products
Deadline for submitting contributions to the proposal for the revision of RDC 327/2019 ended this Monday (2). Participation exceeded 7,000 forms
Logistics, Regulation, and Security: The Impasse on Storing Cannabis in Brazil
In Deusa Cast, experts discuss the possibility of storing cannabis-based products in Brazil. Regulatory advances, legal obstacles, and logistical impacts were debated in light of RDCs 660 and 327
Logistics, Regulation, and Security: The Impasse on Storing Cannabis in Brazil
In Deusa Cast, experts discuss the possibility of storing cannabis-based products in Brazil. Regulatory advances, legal hurdles, and logistical impacts were debated in light of RDCs 660 and 327
How to Import Cannabis Products
The Sechat Portal spoke with Courier Brasil Express to address the main questions patients have regarding the importation of medications.
More than 500 companies offer cannabis products to Brazil through importation; products now exceed 600
Anvisa points out the USA as the main supplier, followed by Canada, Colombia, and Uruguay